Roux-en-Y gastric bypass surgery is associated with remission from type 2 diabetes and substantially reduced the risk for microvascular complications.
Boehringer Ingelheim and Lilly announced that the CAROLINA trial met its primary endpoint, demonstrating no increased cardiovascular (CV) risk with linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, when compared with glimepiride, a sulfonylurea, in patients with type 2 diabetes and CV risk.
There is an increased risk for intracerebral hemorrhage in patients with diabetes and uncontrolled glycated hemoglobin.
Type 2 diabetes is associated with significantly increased frailty and fracture risk compared with the general population.
In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Unrestricted home use of day and night hybrid closed-loop insulin is safe and feasible for very young children.
Compared with men, women who have diabetes experience greater changes in the cumulative burden of cardiovascular risk factors from young to middle-age adulthood.
Irrespective of age and weight, women with polycystic ovary syndrome have an increased risk for type 2 diabetes.
Higher levels of vitamin D-binding protein at the time of delivery, but not during the middle of pregnancy, were associated with a lower risk for type 1 diabetes.
For patients with type 2 diabetes and left ventricular hypertrophy, empagliflozin reduced the risk for cardiovascular death vs placebo.